메뉴 건너뛰기




Volumn 135, Issue 6, 2010, Pages 1309-1314

Establishment of a novel colorimetric assay for high-throughput analysis of calcium oxalate crystal growth modulation

Author keywords

[No Author keywords available]

Indexed keywords


EID: 77952817927     PISSN: 00032654     EISSN: 13645528     Source Type: Journal    
DOI: 10.1039/b927046a     Document Type: Article
Times cited : (10)

References (22)
  • 1
    • 0023228440 scopus 로고
    • Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid
    • Y. Nakagawa M. Ahmed S. L. Hall et al. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid J. Clin. Invest. 1987 79 1782
    • (1987) J. Clin. Invest. , vol.79 , pp. 1782
    • Nakagawa, Y.1    Ahmed, M.2    Hall, S.L.3
  • 2
    • 0026571598 scopus 로고
    • Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein superfamily
    • H. Shiraga W. Min W. J. VanDusen et al. Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily Proc. Natl. Acad. Sci. U. S. A. 1992 89 426
    • (1992) Proc. Natl. Acad. Sci. U. S. A. , vol.89 , pp. 426
    • Shiraga, H.1    Min, W.2    Vandusen, W.J.3
  • 3
    • 0028874829 scopus 로고
    • The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro
    • R. L. Ryall P. K. Grover A. M. Stapleton et al. The urinary F1 activation peptide of human prothrombin is a potent inhibitor of calcium oxalate crystallization in undiluted human urine in vitro Clin. Sci. (Lond) 1995 89 533
    • (1995) Clin. Sci. (Lond) , vol.89 , pp. 533
    • Ryall, R.L.1    Grover, P.K.2    Stapleton, A.M.3
  • 4
    • 0032706470 scopus 로고    scopus 로고
    • Role of urinary bikunin in the inhibition of calcium oxalate crystallization
    • F. Atmani S. R. Khan Role of urinary bikunin in the inhibition of calcium oxalate crystallization J. Am. Soc. Nephrol. 1999 10 Suppl. 14 S385
    • (1999) J. Am. Soc. Nephrol. , vol.10 , Issue.SUPPL. 14 , pp. 385
    • Atmani, F.1    Khan, S.R.2
  • 5
    • 31044450826 scopus 로고    scopus 로고
    • Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor
    • S. Chutipongtanate Y. Nakagawa S. Sritippayawan et al. Identification of human urinary trefoil factor 1 as a novel calcium oxalate crystal growth inhibitor J. Clin. Invest. 2005 115 3613
    • (2005) J. Clin. Invest. , vol.115 , pp. 3613
    • Chutipongtanate, S.1    Nakagawa, Y.2    Sritippayawan, S.3
  • 6
    • 0024350038 scopus 로고
    • Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulfate in calcium oxalate urolithiasis
    • F. Grases C. Genestar A. Conte et al. Inhibitory effect of pyrophosphate, citrate, magnesium and chondroitin sulfate in calcium oxalate urolithiasis Br. J. Urol. 1989 64 235
    • (1989) Br. J. Urol. , vol.64 , pp. 235
    • Grases, F.1    Genestar, C.2    Conte, A.3
  • 7
    • 59349104752 scopus 로고    scopus 로고
    • Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation
    • M. R. Robinson V. A. Leitao G. E. Haleblian et al. Impact of long-term potassium citrate therapy on urinary profiles and recurrent stone formation J. Urol. 2009 181 1145
    • (2009) J. Urol. , vol.181 , pp. 1145
    • Robinson, M.R.1    Leitao, V.A.2    Haleblian, G.E.3
  • 8
    • 70249127549 scopus 로고    scopus 로고
    • Pharmacological interventions for preventing complications in idiopathic hypercalciuria
    • J. Escribano A. Balaguer F. Pagone et al. Pharmacological interventions for preventing complications in idiopathic hypercalciuria Cochrane Database Syst Rev 2009
    • (2009) Cochrane Database Syst Rev
    • Escribano, J.1    Balaguer, A.2    Pagone, F.3
  • 9
    • 0022395335 scopus 로고
    • Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis
    • Y. Nakagawa V. Abram J. H. Parks et al. Urine glycoprotein crystal growth inhibitors. Evidence for a molecular abnormality in calcium oxalate nephrolithiasis J. Clin. Invest. 1985 76 1455
    • (1985) J. Clin. Invest. , vol.76 , pp. 1455
    • Nakagawa, Y.1    Abram, V.2    Parks, J.H.3
  • 10
    • 40849151863 scopus 로고    scopus 로고
    • Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation
    • V. Thongboonkerd S. Chutipongtanate T. Semangoen et al. Urinary trefoil factor 1 is a novel potent inhibitor of calcium oxalate crystal growth and aggregation J. Urol. 2008 179 1615
    • (2008) J. Urol. , vol.179 , pp. 1615
    • Thongboonkerd, V.1    Chutipongtanate, S.2    Semangoen, T.3
  • 11
    • 0027263255 scopus 로고
    • A new approach to studying inhibitors of calcium oxalate crystal growth
    • C. Hennequin V. Lalanne M. Daudon et al. A new approach to studying inhibitors of calcium oxalate crystal growth Urol. Res. 1993 21 101
    • (1993) Urol. Res. , vol.21 , pp. 101
    • Hennequin, C.1    Lalanne, V.2    Daudon, M.3
  • 12
    • 67049173045 scopus 로고    scopus 로고
    • Colorimetric high-throughput screen for detection of heme crystallization inhibitors
    • M. A. Rush M. L. Baniecki R. Mazitschek et al. Colorimetric high-throughput screen for detection of heme crystallization inhibitors Antimicrob. Agents Chemother. 2009 53 2564
    • (2009) Antimicrob. Agents Chemother. , vol.53 , pp. 2564
    • Rush, M.A.1    Baniecki, M.L.2    Mazitschek, R.3
  • 13
    • 54249109815 scopus 로고    scopus 로고
    • A colorimetric microplate assay method for high-throughput analysis of arginase activity in vitro
    • E. W. Iyamu T. Asakura G. M. Woods A colorimetric microplate assay method for high-throughput analysis of arginase activity in vitro Anal. Biochem. 2008 383 332
    • (2008) Anal. Biochem. , vol.383 , pp. 332
    • Iyamu, E.W.1    Asakura, T.2    Woods, G.M.3
  • 14
    • 33845252936 scopus 로고    scopus 로고
    • Colorimetric diffusion-reflection imaging high-throughput analysis of organic or inorganic compounds
    • J. P. Yi L. Huang Z. W. Jiang et al. Colorimetric diffusion-reflection imaging high-throughput analysis of organic or inorganic compounds J. Comb. Chem. 2006 8 881
    • (2006) J. Comb. Chem. , vol.8 , pp. 881
    • Yi, J.P.1    Huang, L.2    Jiang, Z.W.3
  • 15
    • 0026871349 scopus 로고
    • Single stable reagent (Arsenazo III) for optically robust measurement of calcium in serum and plasma
    • N. O. Leary A. Pembroke P. F. Duggan Single stable reagent (Arsenazo III) for optically robust measurement of calcium in serum and plasma Clin. Chem. 1992 38 904
    • (1992) Clin. Chem. , vol.38 , pp. 904
    • Leary, N.O.1    Pembroke, A.2    Duggan, P.F.3
  • 16
    • 0023238527 scopus 로고
    • The calcium-sensitive dye arsenazo III inhibits calcium transport and ATP hydrolysis by the sarcoplasmic reticulum calcium pump
    • S. Riollet P. Champeil The calcium-sensitive dye arsenazo III inhibits calcium transport and ATP hydrolysis by the sarcoplasmic reticulum calcium pump Anal. Biochem. 1987 162 160
    • (1987) Anal. Biochem. , vol.162 , pp. 160
    • Riollet, S.1    Champeil, P.2
  • 17
    • 0021827629 scopus 로고
    • Regional distribution of calcium influx into bursting neurons detected with arsenazo III
    • K. Graubard W. N. Ross Regional distribution of calcium influx into bursting neurons detected with arsenazo III Proc. Natl. Acad. Sci. U. S. A. 1985 82 5565
    • (1985) Proc. Natl. Acad. Sci. U. S. A. , vol.82 , pp. 5565
    • Graubard, K.1    Ross, W.N.2
  • 18
    • 0018508824 scopus 로고
    • Modification of the o-cresolphthalein complexone method for determining calcium
    • S. A. Cohen L. Sideman Modification of the o-cresolphthalein complexone method for determining calcium Clin. Chem. 1979 25 1519
    • (1979) Clin. Chem. , vol.25 , pp. 1519
    • Cohen, S.A.1    Sideman, L.2
  • 19
    • 0020163121 scopus 로고
    • The dissolution of calcium oxalate kidney stones. A kinetic study
    • B. B. Tomazic G. H. Nancollas The dissolution of calcium oxalate kidney stones. A kinetic study J. Urol. 1982 128 205
    • (1982) J. Urol. , vol.128 , pp. 205
    • Tomazic, B.B.1    Nancollas, G.H.2
  • 20
    • 0019485686 scopus 로고
    • Affinity and stoichiometry of calcium binding by arsenazo III
    • P. J. Bauer Affinity and stoichiometry of calcium binding by arsenazo III Anal. Biochem. 1981 110 61
    • (1981) Anal. Biochem. , vol.110 , pp. 61
    • Bauer, P.J.1
  • 21
    • 0031886807 scopus 로고    scopus 로고
    • Influence of calcium on glucose biosensor response and on hydrogen peroxide detection
    • N. Labat-Allietta D. R. Thevenot Influence of calcium on glucose biosensor response and on hydrogen peroxide detection Biosens. Bioelectron. 1998 13 19
    • (1998) Biosens. Bioelectron. , vol.13 , pp. 19
    • Labat-Allietta, N.1    Thevenot, D.R.2
  • 22
    • 33645846936 scopus 로고    scopus 로고
    • Factors determining types and morphologies of calcium oxalate crystals: Molar concentrations, buffering, pH, stirring and temperature
    • V. Thongboonkerd T. Semangoen S. Chutipongtanate Factors determining types and morphologies of calcium oxalate crystals: Molar concentrations, buffering, pH, stirring and temperature Clin. Chim. Acta 2006 367 120
    • (2006) Clin. Chim. Acta , vol.367 , pp. 120
    • Thongboonkerd, V.1    Semangoen, T.2    Chutipongtanate, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.